Advertisement

Topics

PubMed Journals Articles About "A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine To Amphotericin B Alone Followed By A Comparison Of Fluconazole And Itraconazole In The Treatment Of Acute Cryptococcal Meningitis" RSS

18:13 EDT 22nd March 2019 | BioPortfolio

A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine To Amphotericin B Alone Followed By A Comparison Of Fluconazole And Itraconazole In The Treatment Of Acute Cryptococcal Meningitis PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine To Amphotericin B Alone Followed By A Comparison Of Fluconazole And Itraconazole In The Treatment Of Acute Cryptococcal Meningitis articles that have been published worldwide.

More Information about "A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine To Amphotericin B Alone Followed By A Comparison Of Fluconazole And Itraconazole In The Treatment Of Acute Cryptococcal Meningitis" on BioPortfolio

We have published hundreds of A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine To Amphotericin B Alone Followed By A Comparison Of Fluconazole And Itraconazole In The Treatment Of Acute Cryptococcal Meningitis news stories on BioPortfolio along with dozens of A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine To Amphotericin B Alone Followed By A Comparison Of Fluconazole And Itraconazole In The Treatment Of Acute Cryptococcal Meningitis Clinical Trials and PubMed Articles about A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine To Amphotericin B Alone Followed By A Comparison Of Fluconazole And Itraconazole In The Treatment Of Acute Cryptococcal Meningitis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine To Amphotericin B Alone Followed By A Comparison Of Fluconazole And Itraconazole In The Treatment Of Acute Cryptococcal Meningitis Companies in our database. You can also find out about relevant A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine To Amphotericin B Alone Followed By A Comparison Of Fluconazole And Itraconazole In The Treatment Of Acute Cryptococcal Meningitis Drugs and Medications on this site too.

Showing "Randomized Double Blind Protocol Comparing Amphotericin With Flucytosine" PubMed Articles 1–25 of 9,100+

The Effects of Probiotics on Symptoms of Depression: Protocol for a Double-Blind Randomized Placebo-Controlled Trial.

A growing body of evidence has linked mental health outcomes to the gut microbiome. This has led to the investigation of the GI tract as a target for novel treatments and interventions for depression, including probiotic supplementation. Our recent pilot study provided the first evidence of probiotics improving symptoms of depression in treatment-naive depressed patients. To further support and expand upon this evidence, data from the pilot study were used to plan a 16-week, double-blind, randomized, placeb...


In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species.

Cryptococcus species are an encapsulated fungal pathogen that cause cryptococcal meningitis. There are limited therapeutic options for this infection. The management includes the use of different antifungals such as amphotericin B, flucytosine, or fluconazole, either alone or in combination. However, numerous therapeutic failures, as well as the limited effectiveness of such therapeutics, have been described. Diphenyl diselenide is a chemically synthesized molecule with was found to have antimicrobial activ...

Comparison of oncological benefits of deep neuromuscular block in obese patients with gastric cancer (DEBLOQS_GC study): A study protocol for a double-blind, randomized controlled trial: Erratum.


A Randomized Double-blind Clinical Trial of Dentin Surface Treatments for Composite Restorations in Noncarious Cervical Lesions: A 36-month Evaluation.

This randomized, double-blind clinical trial aimed to evaluate the influence of different dentin surface treatments in noncarious cervical lesions (NCCLs).

Influence of a medialized middle turbinate on olfactory function: a prospective randomized double-blind study.

Medialization of the middle turbinate (MT) is an effective technique to prevent recurrent rhinosinusitis but could, in theory, reduce olfactory function by interfering the odorants to reach the olfactory mucosae. We performed a prospective randomized double-blind trial under the hypothesis that olfactory functions would be affected by the status of olfactory mucosae, not by MT medialization.

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

Vedolizumab safety and efficacy have been established in many populations all over the world, but have never been studied in Japan. We report results from a Phase 3, randomized, double-blind, placebo-controlled study of vedolizumab in Japanese patients with active ulcerative colitis (UC).

Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.

The purpose of this randomized, placebo-controlled, double-blind study was to investigate the preventive effect of topical administration of atorvastatin (ATV) on the acute radiation-induced skin toxicity in patients with breast cancer.

A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males.

CT-P16 is a candidate biosimilar of bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor that is used in the treatment of a range of advanced solid cancers.

Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.

The aim of this double-blind randomized study was to evaluate the response to antipsychotic treatment in schizophrenia patients with predicted high/low risk of nonresponse identified by applying a set of well-established scales and predictors of outcome and to compare efficacy between ziprasidone and haloperidol.

Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial.

To evaluate the efficacy and safety of anakinra in treating acute gout flares in a randomized, double-blind, placebo-controlled, active comparator, non-inferiority (NI) trial.

Spinal Manipulative Therapy Effects in Autonomic Regulation and Exercise Performance in Recreational Healthy Athletes: A Randomized Controlled Trial.

Randomized, double blind, parallel groups, sham-controlled trial.

Short-Term Effects of Manual Therapy in Patients After Surgical Fixation of Ankle and/or Hindfoot Fracture: A Randomized Clinical Trial.

Multi-site double blind randomized clinical trial.

The addition of platelet-rich plasma to facial lipofilling: a double-blind, placebo-controlled, randomized trial.

Reply to: "The addition of Platelet-rich Plasma to facial lipofilling: A Double-Blind, Placebo-Controlled, Randomized Trial."

Altered immunogenicity of 23-valent pneumococcal polysaccharide vaccine in elderly patients with diabetes who revealed lower responses to concomitant administration of BIKEN varicella zoster vaccine: Results of post hoc analysis of a randomized double-blind trial.

This double-blind randomized controlled study of 52 elderly patients with diabetes assessed cell-mediated immunity and safety of BIKEN varicella-zoster vaccine (BVZV). Cellular and humoral responses to VZV at 3 months after BVZV and 23-valent polysaccharide pneumococcal vaccine (PPSV23) vaccination elicited poor results. Post-hoc analyses assessed the effects of immunogenicity of PPSV23.

Toreforant, an orally active histamine H-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study.

In a double-blind, placebo-controlled, multiple-dose study, we assessed the molecular mechanism of action of the selective histamine-4-receptor antagonist toreforant.

Randomized in situ study on the efficacy of CO laser irradiation in increasing enamel erosion resistance.

The aim of this double-blind, randomized in situ study was to evaluate the erosion-preventive effect of a specific set of CO laser parameters, associated or not with fluoride.

Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study.

This multicenter, double-blind phase II study assessed the antitumor activity and toxicity profile of docetaxel with the antiangiogenic multikinase inhibitor sorafenib or matching placebo as a first-line treatment in patients with metastatic or locally advanced HER2-negative breast cancer.

0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial.

A randomized, double-blinded, crossover, placebo controlled trial was conducted to evaluate the efficacy and safety of 0.075% capsaicin lotion for treating painful diabetic neuropathy (PDN).

Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial.

Curcumin has shown to exert a positive impact on human glucose metabolism, even if its bioavailability is usually very low. The present study aimed to explore the effect of phosphatidylserine- and piperine-containing curcumin phytosomes on a large number of metabolic parameters related to insulin resistance, in the context of a randomized double-blind placebo-controlled trial involving 80 overweight subjects with suboptimal fasting plasma glucose.

Cluster-Randomized Trials: Methodical and Practical Implications.

Quite often critics demand more randomized studies in rehabilitation science to gather methodological evidence of high quality. However, it is also recognized that the design of double-blind, placebo-controlled, randomized studies often cannot simply be transferred into rehabilitation science. Validity concerning the health care is here in the focus. Thus, treatment as-usual is mostly used as placebo treatment and double-blinding is partly not definable. Additionally, it is often difficult to offer 2 simila...

Comparing Gelfoam vs. fat as a sealing material in stapedotomy; A prospective double blind randomized clinical trial.

One research aspect of stapes surgery is various materials that are used to seal the oval window. Several materials are used to seal the oval window, for example; adipose tissue, perichondrium, vein graft, gelatin sponge (Gelfoam), blood clot, and soft connective tissue. Up to now, there has been no randomized clinical trial that has evaluated the effects of different types of sealing material on hearing outcomes after stapedotomy. Hence, the present study aimed to find out which of these materials; fat or ...

Randomized, double-blind, multicenter trial of hydrogen water for Parkinson's disease.

The Efficacy of Omega-3 Fatty Acids for Depressive Symptoms among Pregnant Women in Japan and Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial (SYNCHRO; NCT01948596).

Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomised studies (DOROTHEO 1 and DOROTHEO 2).

This pooled analysis of double-blind, randomized, placebo-controlled trials aimed to investigate the Impact of DOxofylline compaRed tO THEOphylline (DOROTHEO 1 and DOROTHEO 2 studies) on functional and clinical outcomes in asthma. Patients with asthma ≥16 years of age with (forced expiratory volume in 1 s [FEV] ≥50% and


Advertisement
Quick Search
Advertisement
Advertisement